Personalized Risk Prediction for Prevention and Early Detection of Postoperative Failure to Rescue
Project Number5R01EB035028-02
Contact PI/Project LeaderCANNESSON, MAXIME
Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
Abstract
In the Hospital of the Future hospitalization will be reserved almost exclusively for patients with severe acute
illness, staff numbers will be reduced, and hospitals will be built around smart environments that facilitate
consistent delivery of effective, equitable, and error-free care focused on patient-centered rather than provider-
centered outcomes. This is particularly relevant to the surgical population. While ambulatory surgical centers
are the fastest growing providers, more than 51 million inpatients procedures are performed annually in
hospitals in the US and inpatient surgery centers are taking care of sicker and older patients. While
intraoperative mortality is rare due to improvements in surgical techniques, anesthesia management, and
intraoperative monitoring, global postoperative mortality remains the third leading cause of death among
American People. Recent studies have shown that while the incidence of postoperative major complications
after major surgery is similar between hospitals (~25%), the postoperative mortality following postoperative
major complications from one hospital to the other can be up to 2.5-fold higher. This suggests that reducing
variations in mortality following major surgery will require strategies to improve the ability of high-mortality
hospitals to manage postoperative major complications and decrease failure-to-rescue. One of the solutions
identified is to leverage Health Information Technologies. The goal of this proposal is to use machine learning
approaches to develop, validate, and test real-time postoperative risk prediction tools based on multi-modal
data sources using electronic health record data, high-fidelity physiological waveform features, and genomic
data to identify patients who are at risk of developing postoperative major complications after surgery. Using
extensive electronic health record derived annotation augmented with high-fidelity physiological waveform
features and genomic data and applying state-of-the-art machine learning approaches, common patterns in
subjects destined to develop postoperative major complications and those at very low risk of developing
postoperative major complications after surgery will be characterized and quantified. These inputs will then be
used in simulated real-time bedside management to iteratively design a prototype clinical decision support tool.
This clinical decision support tool will be used at discharge from the post anesthesia care unit to identify
surgical patients who will benefit from continuous remote monitoring and early warning system on the ward to
prevent postoperative failure to rescue. The feasibility and acceptability of this approach will then be assessed
in a small-scale prospective, longitudinal pilot evaluation in sequential 10-weeks, 13-weeks, 10-weeks phases
at UCLA to help design a future, large-scale clinical trial.
Public Health Relevance Statement
Project Narrative
The goal of this proposal is to apply machine learning approaches to multiple data sources including electronic
health record data, high-fidelity physiological waveform data, and genomic data that have never been used
together in the acute care setting to predict postoperative major complications and decrease failure-to-rescue
after surgery. These inputs will be used in simulated real-time bedside management to 1) iteratively design a
prototype clinical decision support tool and 2) evaluate its use in simulation upon use of postoperative
continuous remote monitoring and early warning systems, accuracy and time to correct diagnosis, accuracy
of intervention, and time-to-intervention. The feasibility and acceptability of this clinical decision support tool will
then be assessed in a small-scale prospective, longitudinal pilot evaluation in sequential 10-weeks, 13-weeks,
10-weeks phases to help design a future, large-scale clinical trial.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
092530369
UEI
RN64EPNH8JC6
Project Start Date
01-September-2023
Project End Date
31-August-2027
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$526,149
Direct Costs
$390,436
Indirect Costs
$135,713
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$526,149
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB035028-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB035028-02
Patents
No Patents information available for 5R01EB035028-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB035028-02
Clinical Studies
No Clinical Studies information available for 5R01EB035028-02
News and More
Related News Releases
No news release information available for 5R01EB035028-02
History
No Historical information available for 5R01EB035028-02
Similar Projects
No Similar Projects information available for 5R01EB035028-02